Related Experiment Video
Updated: Apr 17, 2026

07:14
Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae
Published on: February 25, 2022
6.7K
Linking RNA Dysfunction and Neurodegeneration in Amyotrophic Lateral Sclerosis
1Department of Neurology, University of Michigan, 109 Zina Pitcher Place, 5015 Biomedical Sciences Research Building, SSPC 2200, Ann Arbor, MI, 48109, USA, sbarmada@umich.edu.
Summary
Abnormal RNA processing contributes to motor neuron loss in amyotrophic lateral sclerosis (ALS). This review explores RNA dysfunction mechanisms and potential therapeutic targets for ALS.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by motor neuron degeneration.
- Genetic and functional evidence implicates RNA processing and metabolism abnormalities in ALS pathogenesis.
- Key pathological features include mislocalized RNA-binding proteins and mutations in RNA processing genes.
Purpose of the Study:
- To review the current understanding of RNA dysfunction in ALS.
- To identify converging mechanisms of neurodegeneration driven by RNA abnormalities.
- To highlight potential therapeutic targets for ALS.
Main Methods:
- Literature review of genetic and functional studies in ALS.
- Analysis of RNA metabolism pathways and their link to neurodegeneration.
- Identification of conserved pathways implicated in motor neuron loss.
Main Results:
- Abnormal RNA localization and aggregation of RNA-binding proteins are hallmarks of sporadic ALS.
- Mutations in RNA processing genes and C9orf72 repeat expansions cause familial ALS.
- Nuclear RNA foci in C9orf72-ALS underscore RNA metabolism's role.
Conclusions:
- Dysfunctional RNA metabolism is a central mechanism in both sporadic and familial ALS.
- Understanding these RNA-related pathways is crucial for developing effective ALS therapies.
- Targeting early, conserved pathways offers promise for future ALS treatments.
Related Concept Videos
RNA Splicing
61.9K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
61.9K
RNA Splicing
21.0K
21.0K
RNA Editing
10.2K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
10.2K
RNA Stability
36.5K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
36.5K
Amyloid Fibrils
13.2K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
13.2K
Amyloid Fibrils
7.0K
7.0K

